 SOUTH SAN FRANCISCO, Calif., July 09, 2021 GLOBE NEWSWIRE -- VistaGen Therapeutics NASDAQ: VTGN, a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system CNS disorders, today announced that management will participate in the Updates in Neuropsych panel at the virtual William Blair Biotech Focus Conference 2021 on July 15, 2021 at 9:00 a.m. PT. VistaGen will also be participating in one-on-one meetings throughout the conference. 